Quick swab test could cut unnecessary antibiotics in ICU pneumonia care
NCT ID NCT06272994
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed trial tested whether a rapid MRSA nasal swab test could help doctors safely stop an antibiotic called vancomycin in adults with pneumonia in the intensive care unit. 277 participants were randomly assigned to have their swab results reported to their doctor or to receive usual care. The goal was to see if the test reduced time on vancomycin without harming patients.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
MRSA nasal swab PCR test
What this could lead to
If successful, this approach could reduce unnecessary antibiotic use and side effects in hospitalized pneumonia patients.
What could go wrong
This is a single-center, pragmatic trial with 277 participants, so results may not apply broadly. The test only rules out MRSA, not other bacteria.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COMMUNITY-ACQUIRED PNEUMONIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37232, United States